Smith & Nephew plc (LON:SN)
London · Delayed Price · Currency is GBP · Price in GBX 1,143.50
+21.50 (1.92%)
May 19, 2026, 11:24 AM GMT
Smith & Nephew Market Cap
Smith & Nephew has a market cap or net worth of 9.58 billion as of May 19, 2026. Its market cap has increased by 2.58% in one year.
Market Cap
9.58B
Enterprise Value
11.64B
Revenue
4.58B
Ranking
n/a
PE Ratio
21.09
Stock Price
1,143.50
Market Cap Chart
Since December 31, 1985, Smith & Nephew's market cap has increased from 819.93M to 9.58B, an increase of 1,068.69%. That is a compound annual growth rate of 6.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 9.58B | -8.95% |
| Dec 31, 2025 | 10.52B | 21.72% |
| Dec 31, 2024 | 8.65B | -7.88% |
| Dec 29, 2023 | 9.39B | -2.72% |
| Dec 30, 2022 | 9.65B | -15.11% |
| Dec 31, 2021 | 11.36B | -14.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.64B |
| GSK plc | 74.35B |
| Haleon | 29.56B |
| Convatec Group | 4.14B |
| Hikma Pharmaceuticals | 3.09B |
| Genus | 1.61B |
| HUTCHMED (China) | 1.59B |
| Oxford Nanopore Technologies | 1.17B |